Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients receiving Thrombectomy: Standard or Low Dose Therapy?

Conclusions - Compared to standard dose treatment, low dose rtPA may have similar clinical efficacy and safety outcomes in AIS patients receiving bridging therapy.
PMID: 30014803 [PubMed - as supplied by publisher]

Source: Current Neurovascular Research - July 16, 2018 Category: Neurology Authors: Lin CH, Liu CH, Wang AY, Wu YM, Chen CC, Tsai YH, Chang TY, Huang KL, Wu HC, Lee TH, Chang YJ, Lin CM, Cheng CK, Chang CH Tags: Curr Neurovasc Res Source Type: research